Aligos Therapeutics (ALGS) Q3 2023 Earnings

Nov 2Confirmed
Q4 2022
Q1 2023
Q2 2023
Q3 2023
-0.53
-0.49
-0.45
-0.41

Details

Expected EPS
-0.47
Actual EPS
-0.41
Surprise EPS
0.06
Surprise Percent
+12.77%

Description

⁨Aligos Therapeutics⁩ (⁦ALGS⁩) has reported earnings of ⁦-0.41⁩ per share for ⁦Q3 2023⁩.

0 Comments

Share your thoughts